Interviewing Manufacturing Pharmaceutical 
Mad in America
MARCH 22, 2025
The journal continued to be in good hands, and thus one of the few journals that was receptive to research findings that belied the narrative of therapeutic progress that the psychiatric guild and pharmaceutical companies have been promoting for decades. He noted too the reluctance of the field to consider this possibility.
Office Snapshots
MARCH 12, 2024
Sheldon’s workplace design for global pharmaceuticals company Novo Nordisk breaks conventional workplace norms by separating two floors into a collaboration floor and a focus floor, catering to neurodiverse needs. Natural lighting and Sydney Harbour views are optimised, with plenty of seating directly on the perimeter.
Mad in America
OCTOBER 18, 2023
Listen to the audio of the interview here. For the pharmaceutical industry, the bigger and wider those diseases, the more people who can be diagnosed, and the bigger your markets are. For the pharmaceutical industry, the bigger and wider those diseases, the more people who can be diagnosed, and the bigger your markets are.
Mad in America
OCTOBER 30, 2023
There was no placebo group, and all patients started on citalopram, manufactured by Lundbeck, which was motivated by horrendously erroneous claims of citalopram’s “absence of discontinuation symptoms” and its “safety” in elderly patients. Nothing in Insel’s narrative would harm psychiatry’s guild interests or pharmaceutical interests.
Great Place to Work
JUNE 4, 2025
A dedicated team interviewed employees at all levels of the business on how AI might improve their work environment. Stryker , a biotechnology manufacturer, calculated that it has impacted over 130 million patients annually using a methodology developed by a cross-functional team of experts a figure that fills employees with pride!
Inside Workplace Wellness
AUGUST 1, 2018
The arrangement would have been the first agreement with a manufacturer for outcomes-based pricing. Does your PBM require providers to use NDC coding for Specialty Pharmaceuticals to improve monitoring and tracking of utilization? Earlier this month CMS suspended a plan to pay for Norvatis ’ Kymriah therapy based on how well it worked.
Workplace Insight
DECEMBER 14, 2023
It is striking how weighted Ireland’s export figures are to the life sciences, medical and pharmaceutical industries craved by the UK Just how significant is apparent when comparing the UK with Ireland. We are at something of a tipping point if we don’t make the right decisions now,” said Emma Walmsley.
Expert insights. Personalized for you.
136 
Let's personalize your content